Revealing Novel Angiotensin‐Converting Enzyme (ACE)‐Inhibitory Peptides From Mackerel Hydrolysates and Potential Antihypertensive Mechanism Using Virtual Screening and Network Pharmacology Analysis

Angiotensin-converting enzyme-inhibitory (ACE-I) peptides derived from marine proteins have received widespread attention for their high efficiency and safety in the management of hypertension. In this study, the mackerel (Scomber japonicus) muscle papain hydrolysate (MMPH) was isolated via ultrafiltration and gel chromatography. Then peptides with ACE-I activity were screened using LC-MS/MS and virtual screening. Ten novel ACE-I peptides were identified from MMPH. In which, APFLAG showed the greatest inhibitory effects in vitro with an IC<sub>50</sub> value of 69.45 ± 2.93 µM, followed by FDHKKFF (212.85 ± 3.19 µM) and LFPKFA (259.05 ± 3.72 µM). Molecular docking studies revealed that all these three peptides bind to S<sub>1</sub> and S<sub>2</sub> pockets, while APFLAG and LFPKFA interacted with the zinc (Zn)-binding domain residues and only FDHKKFF interacted with the S<sub>1</sub>' pocket of ACE. Furthermore, the best peptide, APFLAG, inhibited ACE competitively and noncompetitively. Network pharmacology analysis suggested that APFLAG regulates blood pressure by targeting the renin-angiotensin system (RAS) and modulating renin secretion via ACE and renin. Additionally, APFLAG promotes vasodilation and lowers blood pressure by regulating vascular smooth muscle cells through the activation of tyrosine-protein kinase SRC (SRC) and signal transducer and activator of transcription 3 (STAT3). These findings underscore the multifaceted anti-hypertensive mechanisms of APFLAG and highlight its potential for therapeutic management of hypertension. Practical Application: Preparation of mackerel muscle hydrolysate with strong ACE-I activity by papain hydrolysis, ultrafiltration, and gel chromatography. The oligopeptides APFLAG, FDHKKFF, and LFPKFA exhibited excellent ACE-I activity. Producing bioactive peptides is a promising strategy to realize high-value applications of mackerel muscle protein.

Authors

Institutions

Publication Details

Journal
Journal of Food Science
Published
2025-12-01
DOI
https://doi.org/10.1111/1750-3841.70767
Primary Topic
Protein Hydrolysis and Bioactive Peptides
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Revealing Novel Angiotensin‐Converting Enzyme (ACE)‐Inhibitory Peptides From Mackerel Hydrolysates and Potential Antihypertensive Mechanism Using Virtual Screening and Network Pharmacology Analysis

Youping Xie, Zong‐Ping Zheng, Baobei Wang, Fang Wang et al.
Journal of Food Science
Protein Hydrolysis and Bioactive Peptides
article

Revealing Novel Angiotensin‐Converting Enzyme (ACE)‐Inhibitory Peptides From Mackerel Hydrolysates and Potential Antihypertensive Mechanism Using Virtual Screening and Network Pharmacology Analysis

Youping Xie, Zong‐Ping Zheng, Baobei Wang, Fang Wang, Yue Wang, Chenxu Wang, Hui Zhang, Xinyu Zhang
article en

Abstract

Angiotensin-converting enzyme-inhibitory (ACE-I) peptides derived from marine proteins have received widespread attention for their high efficiency and safety in the management of hypertension. In this study, the mackerel (Scomber japonicus) muscle papain hydrolysate (MMPH) was isolated via ultrafiltration and gel chromatography. Then peptides with ACE-I activity were screened using LC-MS/MS and virtual screening. Ten novel ACE-I peptides were identified from MMPH. In which, APFLAG showed the greatest inhibitory effects in vitro with an IC<sub>50</sub> value of 69.45 ± 2.93 µM, followed by FDHKKFF (212.85 ± 3.19 µM) and LFPKFA (259.05 ± 3.72 µM). Molecular docking studies revealed that all these three peptides bind to S<sub>1</sub> and S<sub>2</sub> pockets, while APFLAG and LFPKFA interacted with the zinc (Zn)-binding domain residues and only FDHKKFF interacted with the S<sub>1</sub>' pocket of ACE. Furthermore, the best peptide, APFLAG, inhibited ACE competitively and noncompetitively. Network pharmacology analysis suggested that APFLAG regulates blood pressure by targeting the renin-angiotensin system (RAS) and modulating renin secretion via ACE and renin. Additionally, APFLAG promotes vasodilation and lowers blood pressure by regulating vascular smooth muscle cells through the activation of tyrosine-protein kinase SRC (SRC) and signal transducer and activator of transcription 3 (STAT3). These findings underscore the multifaceted anti-hypertensive mechanisms of APFLAG and highlight its potential for therapeutic management of hypertension. Practical Application: Preparation of mackerel muscle hydrolysate with strong ACE-I activity by papain hydrolysis, ultrafiltration, and gel chromatography. The oligopeptides APFLAG, FDHKKFF, and LFPKFA exhibited excellent ACE-I activity. Producing bioactive peptides is a promising strategy to realize high-value applications of mackerel muscle protein.

Journal of Food ScienceVol. 90(12)
Quanzhou Normal University (CN), Fujian Agriculture and Forestry University (CN), Fuzhou University (CN)
Openalex Percentile: Top 63%
Protein Hydrolysis and Bioactive Peptides
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.